Biomarkers used in trial to prevent systematic onset of Crohns Disease before it begins in Europe-first project 

First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark

Uniphar appoints new global head of Scientific Communications

Pharmapack Predictions 2025: the Good the Bad and…. the Donald 2.0

David Loose appointed CEO of Essex Management

Dr Joerg Moeller appointed CEO of Antag Therapeutics

Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report

University of Sheffield trial highlights immunotherapy-related improved survival rates for bladder cancer patients

AnaCardio raises $19m in funding round for heart failure candidate

IDDI announces two new appointments to its leadership team

University of Southern Denmark pairs with Argobio to launch next-generation RNA company Inverna Therapeutics

NMD Pharma’s Charcot-Marie-Tooth disease treatment granted ODD by FDA

NDA in China receives priority review status for lung cancer treatment

NICE recommendation for KORSERDU®▼ (elacestrant) marks ‘step-change’ in the treatment of ESR1-mutated metastatic breast cancer

MHRA Grants Marketing Authorisation for LEO Pharma’s Anzupgo® ▼(delgocitinib) cream in Great Britain

Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance

Deep Science Ventures and General Inception collaborate to create fibrosis-focused therapeutics company

NICE RECOMMENDS LILLY’S TIRZEPATIDE (MOUNJARO ®▼) FOR MANAGING OVERWEIGHT AND OBESITY IN FINAL DRAFT GUIDANCE

Gemma Cathcart appointed managing partner at Langland

Ceryx Medical Initiates First-In-Human Study of the Cysoni™ RSA Pacemaker

Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens

Great Place To Work® and Fortune Name Chiesi Group No. 23in 2024 World’s Best Workplaces™ List

Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion

Antibacterial peptides instrumental in efficiency against resistant bacteria

Spinal cord stimulator with AI technology receives CE Mark certification